6 Years of In-depth Research with 10 Study Participants.
1 Amazing Discovery.
According to the CDC, up to 2.5 Million People in the U.S., and 22.5 people worldwide, suffer from Chronic Fatigue Syndrome.
The Similarity of CFS to Long COVID is Well Known.
About 25% of C19 Patients Develop Long COVID.
The NIH Estimates that 10 Million Americans
Suffer from Long Covid.
They Share At Least Two Dozen Physical Symptoms.
Fatigue; Loss of Stamina; Headache; Shortness of Breath; Breathing Difficulties; Cough; Post-Nasal Drip; Runny Nose; Blurry Vision; Sore Throat; Abdominal Pain; Nausea or Vomiting; Diarrhea or Constipation; Joint and/or Muscle Pain; Peripheral Neuropathy; Chest Pain, Pressure or Discomfort; Dizziness; Heart Rate Irregularities; Difficulty Sleeping; Difficulty Concentrating; Memory Loss.
We developed and tested precision nutritional supplements that
helped 60% of our Chronic Fatigue Syndrome participants
get out of bed and engage in a more active lifestyle.
TX Genetic Research Offers Unique, Genetic-Based
Testing, and Nutritional Services and Products for CFS.
We Look Forward to Working with Dedicated Investors to
Help Change the Lives of Millions of People.
We are currently preparing our intellectual property for patenting in Fall, 2023.
We are seeking investment to:
1) Extend Our Research to More CFS and to Long C19 Sufferers,
Potentially Expanding Our Target Market by 300%.
2) Recruit Our Executive Team.
3) Arrange Genetic Testing and Reporting Process.
4) Develop and Test Foods and Supplements.
5) Build Out Website and Food-Gene Database.
“Not too long ago I was immobile and sleeping most of the day. I am now employed with a very demanding job. This is strictly due to the guidelines that I got from Helen regarding food and supplements.” JE
“Last weekend, I was able to do five hours of heavy yard work. Three years ago, I was confined to bed and felt awful the whole time.” RL
“Many of Helen’s recommendations have been helpful, especially what supplements and foods not to consume.” AS
Testimonials
They Both Exhibit Autoantibodies to
Neurotransmission Receptors.
And They Display Damage from Oxidative Stress.